Amdoxovir
Amdoxovir is an nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV. It was discovered by R. F. Schinazi (Emory University) and C. K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.
read more [+]| Systematic (IUPAC) name | [(2R,4R)-4-(2,6-Diaminopurin-9-yl)-1,3-dioxolan-2-yl]methanol |
|---|---|
| CAS number | 145514-04-1 |
| ATC code | 124088 |
| PubChem | 124088 |
| DrugBank | |
| Formula: | C9H12N6O3 |
| Molecular mass | 252.23 g/mol |
| Assay/Purity | Typically NLT 98% |
